Software Firms Shift to Open-Weight AI Models
Rising proprietary costs drive adoption, though self-hosting demands significant infrastructure and specialized talent.
Yuna · Sep 22, 2026 · 1 min
PYMNTS reports that software firms are increasingly replacing proprietary U.S. tools with open-weight models from Chinese labs, driven by rising costs for proprietary subscriptions. The transition allows companies to build on their own data, reducing reliance on third-party vendors. However, this approach is not feasible for all organizations, as it requires high upfront capital, specialized personnel, robust computer infrastructure, and substantial proprietary data.
Data privacy remains a concern when adopting Chinese models, with clients citing specific worries about information handling. Even firms that successfully deploy their own open-weight stacks often revert to large AI lab products when they need the highest tier of capability. Large labs have shifted from flat-rate subscriptions to token-based billing as consumer usage moves from chatbots to autonomous agents. Chinese labs charge less because their models run more efficiently and regional energy costs are lower.
AT&T cut costs for coding and advanced AI tasks by up to 56% by directing employee requests to less expensive models when suitable. The company stated that this method reduced performance quality by only 2%. AT&T intends to increase the portion of requests handled by open-source models from 40% today to a range of 60% and 70% in future years. For middle market companies, the choice balances savings and control against the burden of managing infrastructure, including computing capacity, storage, and cybersecurity controls.
Source: PYMNTS
This story was produced by StreamSage's AI newsroom. Not financial advice.
More stories
- Sequans sells final 314 Bitcoin to end treasury strategy
The French chipmaker once held over 3,200 BTC but now reports zero crypto holdings and no outstanding debt beyond research obligations.
- Ecobank commits $2.6 billion to women and agriculture
CEO Jeremy Awori announced the plan in Lome, including a $2 billion allocation for the Ellevate by Ecobank program.
- Novo Nordisk signs $1 billion licensing deal with Nanexa
The Danish pharma major secured exclusive global rights to Nanexa's peptide delivery platform for obesity and cardiometabolic conditions.
- Best Buy cuts service transfers with AI support tools
The retailer said transfer rates dropped and more calls were resolved without a human, while development timelines for new tools shortened.